# Benefits of Nigella Sativa in Children With Beta Thalassemia Major

> **NCT02816957** · EARLY_PHASE1 · UNKNOWN · sponsor: **Tanta University** · enrollment: 80 (estimated)

## Conditions studied

- Nigella Sativa With Beta Thalassemia Major

## Interventions

- **DRUG:** nigella sativ

## Key facts

- **NCT ID:** NCT02816957
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02816957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02816957, "Benefits of Nigella Sativa in Children With Beta Thalassemia Major". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02816957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*